IL155931A0 - 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same - Google Patents

1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL155931A0
IL155931A0 IL15593101A IL15593101A IL155931A0 IL 155931 A0 IL155931 A0 IL 155931A0 IL 15593101 A IL15593101 A IL 15593101A IL 15593101 A IL15593101 A IL 15593101A IL 155931 A0 IL155931 A0 IL 155931A0
Authority
IL
Israel
Prior art keywords
hydrogen atom
group
alkyl group
formula
pharmaceutical compositions
Prior art date
Application number
IL15593101A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL155931A0 publication Critical patent/IL155931A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL15593101A 2000-11-16 2001-11-14 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same IL155931A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000350063 2000-11-16
PCT/JP2001/009960 WO2002040483A1 (fr) 2000-11-16 2001-11-14 Dérivés 1-méthylcarbapenem

Publications (1)

Publication Number Publication Date
IL155931A0 true IL155931A0 (en) 2003-12-23

Family

ID=18823361

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15593101A IL155931A0 (en) 2000-11-16 2001-11-14 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same

Country Status (24)

Country Link
US (1) US7001897B2 (da)
EP (1) EP1340757B1 (da)
KR (1) KR100832287B1 (da)
CN (1) CN1289498C (da)
AT (1) ATE342266T1 (da)
AU (2) AU1521202A (da)
BR (1) BR0115454A (da)
CA (1) CA2429346A1 (da)
CZ (1) CZ300137B6 (da)
DE (1) DE60123827T2 (da)
DK (1) DK1340757T3 (da)
ES (1) ES2273902T3 (da)
HU (1) HUP0303204A3 (da)
IL (1) IL155931A0 (da)
MX (1) MXPA03004372A (da)
NO (1) NO20032198L (da)
NZ (1) NZ525934A (da)
PL (1) PL362132A1 (da)
PT (1) PT1340757E (da)
RU (1) RU2247725C2 (da)
SK (1) SK5982003A3 (da)
TW (1) TWI242013B (da)
WO (1) WO2002040483A1 (da)
ZA (1) ZA200303796B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211291A (pt) * 2001-07-18 2004-08-03 Mitsui Chemicals Inc Derivados de diamina, processo para produção dos derivados de diamina e fungicidas contendo os derivados de diamina como ingrediente ativo
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
EP1637529A1 (en) * 2004-09-20 2006-03-22 4Sc Ag Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
US7601745B2 (en) * 2004-09-27 2009-10-13 4Sc Ag Heterocyclic NF-kB inhibitors
EP2009005A4 (en) 2006-04-19 2010-06-02 Astellas Pharma Inc AZOLECARBOXAMIDE DERIVATIVE
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
SI2206707T1 (sl) 2007-10-24 2014-11-28 Astellas Pharma Inc. Azolkarboksamidna spojina ali njena sol
ES2533826T3 (es) 2008-01-18 2015-04-15 Merck Sharp & Dohme Corp. Inhibidores de beta-lactamasa
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
WO2014097151A2 (en) 2012-12-19 2014-06-26 Novartis Ag Autotaxin inhibitors
AU2022300325A1 (en) * 2021-06-23 2023-11-02 F. Hoffmann-La Roche Ag Process for the preparation of nlrp3 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3784147T2 (de) * 1986-11-24 1993-06-03 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate.
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation
AU682510B2 (en) * 1993-07-01 1997-10-09 Pfizer Japan Inc. 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives
DE4423612A1 (de) 1994-07-06 1996-01-11 Basf Ag 2-[(Dihydro)pyrazolyl-3'-oxymethylen]-anilide, Verfahren zu ihrer Herstelung und ihre Verwendung
TW445265B (en) * 1996-11-25 2001-07-11 Meiji Seika Kaisha Carbapenem derivatives and antimicrobial agents
TW200403244A (en) * 2002-05-14 2004-03-01 Sankyo Co 1β-Methylcarbapenem derivatives for oral use
JP2004043438A (ja) * 2002-05-15 2004-02-12 Sankyo Co Ltd １−メチルカルバペネム誘導体を含有する医薬

Also Published As

Publication number Publication date
EP1340757A4 (en) 2005-01-26
CZ20031325A3 (cs) 2003-10-15
NO20032198D0 (no) 2003-05-15
NO20032198L (no) 2003-07-16
TWI242013B (en) 2005-10-21
NZ525934A (en) 2004-09-24
US7001897B2 (en) 2006-02-21
DE60123827T2 (de) 2007-05-31
CN1289498C (zh) 2006-12-13
CZ300137B6 (cs) 2009-02-18
WO2002040483A1 (fr) 2002-05-23
US20040014962A1 (en) 2004-01-22
RU2247725C2 (ru) 2005-03-10
ATE342266T1 (de) 2006-11-15
HUP0303204A3 (en) 2010-04-28
CA2429346A1 (en) 2002-05-23
ES2273902T3 (es) 2007-05-16
ZA200303796B (en) 2004-08-16
KR20030048151A (ko) 2003-06-18
KR100832287B1 (ko) 2008-05-26
PT1340757E (pt) 2006-12-29
EP1340757A1 (en) 2003-09-03
DK1340757T3 (da) 2007-02-12
HUP0303204A2 (hu) 2003-12-29
DE60123827D1 (en) 2006-11-23
BR0115454A (pt) 2003-09-23
MXPA03004372A (es) 2003-08-19
CN1486317A (zh) 2004-03-31
SK5982003A3 (en) 2004-05-04
AU1521202A (en) 2002-05-27
EP1340757B1 (en) 2006-10-11
AU2002215212B2 (en) 2004-10-14
PL362132A1 (en) 2004-10-18

Similar Documents

Publication Publication Date Title
DE69925141D1 (de) Chinazolin derivate
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
DE60123827D1 (en) 1-methylcarbapenemderivate
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
DE69215694D1 (de) Benzamid-derivate
HUT67259A (en) 5-amino-8-methyl-7-pyrrolidinyl-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing them
AU9233101A (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
IL148196A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
WO2000078793A3 (en) Antimicrobial agents
BG103985A (en) Multicyclic derivatives of erythromycin
YU45994A (sh) Farmaceutski preparati za prevenciju i/ili tretiranje gastrointenstinalnih oboljenja uključujući ulkus